Skip to main content

Syros Pharmaceuticals, Inc.

SYRSDelisted Mar 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001556263

Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Syros Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of SYRS: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders94269−23
Shares44.6M20.0K35.6M−9.03M (−20.2%)
Value$53.1M$24.0K$34.2M−$18.8M (−35.5%)

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (13)

Institutions that held Syros Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to SYRS in Q2 2022
InstitutionSharesValue% of portfolio
Oasis Management Co Ltd.500,000$481.0K0.09%
Ergoteles LLC269,400$259.0K0.01%
Clarius Group, LLC193,483$186.0K0.02%
Qube Research & Technologies Ltd53,565$52.0K0.00%
Prudential Financial Inc33,400$32.0K0.00%
LMR Partners LLP27,380$26.0K0.00%
Verition Fund Management LLC23,196$22.0K0.00%
Orion Portfolio Solutions, LLC20,198$19.0K0.00%
Balyasny Asset Management LLC14,830$14.0K0.00%
Man Group plc–$10.0K0.00%
Y-Intercept (Hong Kong) Ltd10,130$10.0K0.00%
Credit Suisse AG31$00.00%
Simplex Trading, LLC140$00.00%

Sold out (36)

Institutions that held Syros Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Not filed for Q2 2022 yet (2)

Institutions that held Syros Pharmaceuticals, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding SYRS in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC11,874$14.0K
Amalgamated Financial Corp.8,113$10.0K